SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-030453
Filing Date
2021-09-07
Accepted
2021-09-07 07:41:14
Documents
12
Period of Report
2021-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K brhc10028690_8k.htm   iXBRL 8-K 28745
  Complete submission text file 0001140361-21-030453.txt   165583

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA infi-20210901.xsd EX-101.SCH 3911
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE infi-20210901_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE infi-20210901_pre.xml EX-101.PRE 16034
5 EXTRACTED XBRL INSTANCE DOCUMENT brhc10028690_8k_htm.xml XML 4231
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 211238258
SIC: 2834 Pharmaceutical Preparations